{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"47.53","upperLimit":"72.63","value":"61.40"}]}],"title":"1-Year Disease-Free Rate"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"21.45","upperLimit":"45.47","value":"33.24"}]}],"title":"2-Year Disease-Free Rate"}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"}],"units":"Participants"}],"description":"Kaplan-Meier estimates of the percentage of participants still alive at 1-year and 2-years, based upon the total number of participants who had surgery.","dispersionType":"95% Confidence Interval","groups":[{"description":"pemetrexed: 500 mg/m2, intravenous, every 21 days x 4 cycles cisplatin: 75 mg/m2, intravenous, every 21 days x 4 cycles chemotherapy, surgery then chest radiation x 54 gray (Gy)","id":"OG000","title":"Pemetrexed"}],"paramType":"MEAN","populationDescription":"All participants who had undergone surgery.","reportingStatus":"POSTED","timeFrame":"1 year and 2 years","title":"The 1 and 2 Year Disease-Free Survival Rate (Percentage)","type":"SECONDARY","unitOfMeasure":"percentage of participants"}